Zhongyuan Union Cell & Gene Eng
Zhongyuan Union Cell & Gene Eng is principally engaged in the detection and storage of stem cell sources.
Launch date
Employees
Market cap
$1.2b
Enterprise valuation
$1.0b (Public information from Sep 2024)
Share price
CNY17.91 600645.SS
Tianjin Tianjin Shi (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.3b | 1.5b | 1.6b | 1.6b | 1.7b | 1.9b | 2.0b |
| % growth | (5 %) | 16 % | 1 % | 2 % | 9 % | 7 % | 8 % |
| EBITDA | 279m | 414m | 313m | 305m | 347m | 387m | 433m |
| % EBITDA margin | 21 % | 27 % | 20 % | 19 % | 20 % | 21 % | 22 % |
| Profit | (127m) | 155m | 113m | 106m | 147m | 171m | 200m |
| % profit margin | (10 %) | 10 % | 7 % | 7 % | 8 % | 9 % | 10 % |
| EV / revenue | 7.0x | 7.0x | 4.3x | 5.0x | 4.4x | 4.1x | 3.8x |
| EV / EBITDA | 32.9x | 25.8x | 21.4x | 26.3x | 21.8x | 19.6x | 17.5x |
| R&D budget | 114m | 135m | 147m | 184m | - | - | - |
| R&D % of revenue | 9 % | 9 % | 9 % | 12 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Zhongyuan Union Cell & Gene Eng
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
